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Abstract Hypotension is a commonly diagnosed and treated
complication of extremely low gestational age newborns
(ELGAN), but enormous variation in diagnosis, management
and clinical practice has been documented. We sought to
evaluate practice regarding the management of hypotension
in ELGANs and developed a web-based questionnaire ad-
dressing diagnosis, intervention thresholds andmodes of treat-
ment of hypotension in ELGANs.We received 216 completed
questionnaires from respondents in 38 countries. Most re-
sponses (83 %) were from specialist units where, together,
over 26,000 very low birth weight (VLBW) infants are cared
for annually. The majority (73 %) defined hypotension as a
mean blood pressure (BP) in mmHg less than the gestational
age in weeks. Sixty percent assessed the circulation with
additional methods; echocardiographywas the most common-
ly used (74 %), with left ventricular output and fractional
shortening the two most common measurements made. The
majority (85 %) used volume administration as the initial
intervention. Dopamine was the inotrope most commonly
used initially (80 %). If the initial inotrope therapy failed,
dobutamine was the most popular second-line treatment
(28 %). Delayed cord clamping was used at 51 % of the
centres. Conclusion: The definition of hypotension in
ELGANs continues to follow traditional standards.
Functional echocardiography is now used to assess the circu-
lation at many centres. Volume expansion and dopamine
remain the most frequently used therapies.
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Introduction
Hypotension is commonly diagnosed and treated in extremely
low gestational age newborns (ELGANs, less than 28 weeks of
gestation), but large variations in diagnosis, management and
clinical practice have been previously documented [3, 9].
However, many ELGANs with low numerical blood pressure
(BP) values may have adequate systemic perfusion [17].
Previously, many clinicians relied solely on absolute BP
values to guide intervention, and, in some instances, single
absolute mean BP values were chosen over a wide range of
gestational ages [11]. In accordancewith a recommendation of
On behalf of the HIP consortium: Geraldine Boylan, Anthony C. Ryan,
Brendan Murphy, Jan Miletin, Paul Breen, Gérard Pons, Po-Yin Cheung,
David Corcoran and David Van Laere.
Electronic supplementary material The online version of this article
(doi:10.1007/s00431-013-2251-9) contains supplementary material,
which is available to authorized users.
Z. Stranak (*) : J. Semberova
Institute for the Care of Mother and Child, Third Faculty of
Medicine, Charles University, Podolske Nabrezi 157,
147 00 Prague 4, Czech Republic
e-mail: z.stranak@seznam.cz
K. Barrington
Centre Hospitalier Universitaire Sainte-Justine,
5200, rue Bélanger East, Montreal H1T 1C9,
Quebec, Canada
C. O’Donnell
National Maternity Hospital, Holles Street,
Dublin 2, Ireland
N. Marlow
University College London, 6-96 Chenies Mews,
WC1E 6HX London, UK
G. Naulaers
Katholieke Universiteit Leuven, Oude Markt 13,
3000 Leuven, Belgium
E. Dempsey
Department of Paediatrics and Child Health,
Neonatal Intensive Care Unit, Wilton Cork, Ireland
Eur J Pediatr (2014) 173:793–798
DOI 10.1007/s00431-013-2251-9
the Joint Working Group of the British Association of
Perinatal Medicine [5], a mean arterial BP less than the infants
GA has been widely used to diagnose hypotension [3]. This
method of diagnosis has no empirical evidence to support it
but appears to be the historical standard largely by virtue of its
simplicity and clinical availability [5]. There is no validated
clinical scoring system available to assess poor perfusion
associated with apparently low blood pressure values in the
preterm infant. A number of indirect measures applicable at
the bedside include physical and biochemical findings [1].
There has been increased use of ancillary methods to assess
perfusion in the setting of newborn hypotension, including
bedside echocardiography [8, 16]. Enormous variations in the
treatment of hypotension have been documented, which have
not been shown to affect long-term outcomes [17]. The aim of
this survey was to determine current strategies for diagnosing
and treating hypotension in the first 72 h in extremely preterm
infants internationally.
Methods
A web-based questionnaire addressing diagnostic and man-
agement criteria for hypotension in ELGANs was developed
by the Hypotension in the Preterm (HIP) consortium
(http://www.hip-trial.com/hip-home/). This consortium
comprises neonatologists , pharmacologists and
neurophysiologists, and is funded by the European Union
through the Seventh Framework Programme (FP7). The goal
of the consortium is to determine the short- and long-term
outcome of extremely low gestational age newborns treated
with current practices for hypotension during the transitional
period after birth.
We developed a 25-item questionnaire introduced by a
specific scenario, namely, a baby born at 25 weeks of gesta-
tion with a mean blood pressure of 23 mmHg 6 h after birth
(see Appendix). The questions posed related to diagnosis,
methods of assessment and treatment. We collected demo-
graphic and population data, as well as institutional recommen-
dations regarding diagnostic and therapeutic approach to hypo-
tension. Questions evaluated the current strategies for diagnosis
of hypotension including clinical signs, biochemical parame-
ters, use of functional echocardiography, near infrared spec-
troscopy (NIRS), electroencephalography (EEG) and addition-
al methods for circulatory assessment (e.g. central venous
pressure, mixed venous saturation and pulsatility index).
Specific management-related questions addressed which agent
was used first after hypotension has been diagnosed (volume
and inotrope or steroids). If volume therapywas used, we asked
respondents to specify the amount and type of fluid. Clinicians’
preferences for various inotropes were investigated. Particular
agents and their dosing regimens were addressed. Participants
were asked whether they changed their approach to
hypotension management in the presence of a patent ductus
arteriosus that they considered haemodynamically significant.
Other questions related to whether delayed cord clamping was
applied routinely and whether strategies, including ‘permissive
hypotension’ [2]—i.e. ‘watchful waiting’ in preference to im-
mediate intervention for infants with numerically low BP values
in the absence of other signs of poor perfusion—were used.
The survey was distributed in cooperation with the neona-
tologists involved in the HIP consortium, who coordinated
distribution at national level within their own countries to all
Level II and III units. It was also distributed at the European
Society for Paediatric Research meeting in Istanbul, Turkey,
October 2012. The questionnaire was anonymous, and partic-
ipation was voluntary. Returned completed questionnaires from
each physician were taken as consent to participate in the study.
Data were analysed with SPSS statistical software version
19 (IBM, Armonk NY, USA). Following descriptive analysis,
confidence intervals of proportions were calculated for dichot-
omous variables. Analysis of the most common hypotension
treatment method was performed by using contingency tables
using a sign scheme displayed for adjusted standardised re-
siduals. The relationship of selected answers was compared
among various responder groups by using three-dimensional
contingency tables. Analysis of the most common treatment
method was strengthened by the use of cluster analysis based
on treatment method information, cross-referenced to re-
sponder group representation.
Results
We received 221 responses and excluded 5, as data were
incomplete, leaving 216 questionnaires available for analysis.
Most survey respondents (83 %) were from specialist or Level
III centres, and 41 % were affiliated to University hospitals
caring for a combined figure of over 26,000 very low birth
weight (VLBW, <1500 g) infants annually. Characteristics of
the institutions fromwhich participants responded are present-
ed in Table 1. The response rate was 100 % for Irish, Czech
and Belgian centres.
Recommendations for diagnosis and treatment of hypoten-
sion were established in 61 and 65 % of all centres, respec-
tively. Hypotension was defined as a mean BP in mmHg less
than the GA in weeks by 73 % of respondents. Other criteria
including predefined percentile or specific limits believed to
be associated with poor outcome were used significantly less
often (10 and 4 %, respectively); 12 % reported using a
combination of these criteria.
Diagnostic methods of poor perfusion
All respondents assessed perfusion clinically (Fig. 1), with
measurement of capillary refill time (CRT) on the chest the
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preferred method (76 %). This was considered pathological if
it is more than 3 s by 59 % of respondents. Laboratory
methods were used by 75 %, the commonest being both acid
base measurement (70 %) and lactate analysis (70 %). Serum
biomarkers of myocardial dysfunction—including pro-Brain
Natriuretic Peptide, Troponin T and Troponin I—were docu-
mented by 28 % of respondents. Ancillary methods of assess-
ment were used by 60 % of participants (Table 2). Of these,
the most frequently used was echocardiography (74 %).
Table 2 highlights the results of the most commonly reported
echo measurements. The predominant measurement
performed was left ventricular output (LVO) followed by
fractional shortening of left ventricle. Right ventricular output
(RVO) or superior vena cava (SVC) flow was used less
frequently (34 and 38 %, respectively).
Therapeutic approaches to hypotension
Overall 85 % reported giving a fluid bolus as their first
treatment, with the majority (93 %) administering crystalloid.
The initial amount administered was 10 ml/kg by 82 % of
respondents. The total volume given before using another
agent was 20 ml/kg by 59 %, 30 ml/kg by 14 %
and >30 ml/kg in 13 % of centres. Dopamine was the most
Table 1 Institution demographics of survey participants
Characteristic (no. of responders) Number (%)
Level of care provided
(n=215)
Level I 6 (3)
Level II 31 (14)
Level III 178 (83)












Type of hospital (n=215) University hospital 87 (41)
Paediatric hospital 29 (14)







Fig. 1 Proportion of clinical and
laboratory methods used to
evaluate perfusion
Table 2 Ancillary investigations used to evaluate poor perfusion (180
respondents)
Measurement Number (%) 95 % confidence interval
Lower bound Upper bound
ECHO use 134 (75) 68 81
Left cardiac output 87 (65) 57 73
Right cardiac output 45 (34) 26 42
Fractional shortening of
left ventricle
67 (50) 41 59
SVC flow 51 (38) 30 46
Perfusion index 31 (17) 12 23
Temperature measure 85 (47) 40 55
CVP measure 22 (12) 7 17
Mixed venous O2 18 (10) 6 14
EEG/aEEG 6 (3) 1 6
NIRS measurement 27 (15) 10 20
ECHO echocardiography, SVC superior vena cava, CVP central venous
pressure, EEGElectroencephalography, NIRS near infrared spectroscopy
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commonly used first-line inotrope (80 %), used alone (62 %)
or in combination with dobutamine (18 %). The median
starting dose of dopamine was 5 mcg/kg/min, and median
maximum dose was 20 mcg/kg/min. If the BP did not increase
with the initial inotrope infusion, dobutamine with dopamine
was the most popular second-line treatment (28 %). However,
there was great variation in the choice of the second agent
used (Table 3). Seventy-five percent of respondents altered the
therapeutic regime when managing low BP in the presence of
a patent ductus arteriosus (PDA) considered to be haemody-
namically significant. In this situation, indomethacin or ibu-
profen was given by 77 %, with fluid restriction or avoidance
of volume administration less often used (46 and 29 %,
respectively).
Therapeutic regimens
Variables were subjected to the Twostep cluster analysis to
identify respondent groups who follow a similar course of
treatment. The algorithm identified four different clusters, and
the results show that the most prevalent approach to the
hypotension therapy in ELGANs was primary volume admin-
istration followed by inotrope treatment with dopamine.
Responder distribution in the particular clusters was compared
with the number of intensive care beds, number of VLBW
patients, type of institution, existence of institutional guide-
lines and the region. None of the above mentioned variables,
except the region, were found to have similar cluster
representation. Cluster variation in different region is shown
in Table 4.
Finally, the concept of ‘permissive hypotension’—not in-
tervening when the BP is lower than previously accepted
normative values in the absence of any signs of poor perfu-
sion—appears to be an approach that many (80 %) of the
respondents stated that they would consider using.
Discussion
This survey, conducted primarily in Europe, highlights a
number of diagnostic and therapeutic issues. These results
do need to be interpreted cautiously as they may be biassed
and not truly representative of current practice. We are aware
of the limitations of this type of study (the lack of information
on hypotension duration, the lack of clear definition of per-
missive hypotension and good perfusion and the responses
may reflect personal preference rather than unit practice).
Whilst we acknowledge that a survey may not translate into
what one does at the bedside and notwithstanding the above
limitations, taking into account the number of responses ob-
tained, we believe these results are representative of current
management practices.
At most centres, hypotension is defined as mean BP less
than GA [3]. The most common diagnostic method of
assessing perfusion remains clinical evaluation, but there is
increasing use of echocardiography. Though there is little
published evidence of clinical benefit to date, it appears that
the use of functional echocardiography is increasing.
However, we were surprised that LVO rather than RVO was
more commonly evaluated, given the near-universal ductal
patency during this time period [16].
Lactate and base excess are frequently used in the diagnosis
of poor tissue perfusion. A previous study demonstrated that
there was a correlation between raised lactate and poor out-
come and that the prediction of poor outcome is improved if
serial values are considered. Only one study appears to have
correlated lactate values with directly measured systemic
blood flow, and this study noted that there was wide scatter
in the data, which was improved by combining capillary
filling time with the serum lactate values. Serial lactate mea-
surement was used by one half of the respondents in our
survey. The use of other specific markers of myocardial dys-
function (pro BNP, Troponin T and Troponin I) is low [6, 12].
Delayed cord clamping increases circulating blood volume
and appears to lead to improved haemodynamic stability [15].
It is practised by only half of the centres surveyed. The
primary approach to intervention remains administration of
crystalloid in an initial dose of 10 ml/kg. There is a lack of
evidence to support this widespread practice [4]. In addition,
fluid bolus appears to increase mortality in older children with
clinically assessed impaired perfusion [10]. Our survey
Table 3 Choice of inotrope intervention for hypotension (188 respondents)






Dopamine 116 (62) 55 69
Dobutamine 34 (18) 13 24
Dopamine and dobutamine 33 (18) 12 23
Epinephrine 4 (2) 0 4
Norepinephrine 1 (1) 0 2
Second-line treatment
Dopamine 14 (7) 4 11
Dobutamine 42 (22) 16 28
Dopamine and dobutamine 52 (28) 21 34
Epinephrine 32 (17) 12 22
Norepinephrine 18 (10) 5 14
Steroids 18 (10) 5 14
Milrinone 2 (1) 0 3
Notropes and steroids 11 (6) 3 9
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identified that 15 % of respondents do not use volume admin-
istration as a primary intervention. The first-line inotropic
agent in this group is usually dopamine, and this approach
was more prevalent in Southern European respondents.
Dopamine remains the most commonly used inotrope ther-
apy overall. The main reason for using dopamine is the ability
to increase BP, but in preterm infants with low systemic blood
flow (SBF), there is no evidence that dopamine increases
systemic flow. There is some suggestion that dobutamine
may be a better option in increasing and maintaining SBF
[14]. Dobutamine was more often used in Western Europe.
Northern European respondents use volume administration
(alone or combined with inotropes) as their first-line treatment
and tend to choose dopamine as the inotrope of first choice.
Approximately 40% of babies with low SBF fail to respond to
these inotropes [13], and increasingly, respondents are using
other agents such as epinephrine or norepinephrine. Steroids
(usually hydrocortisone) were used only in 10 % of centres as
the second choice of circulatory support. Use of steroids for
refractory hypotension has been studied in a small number of
small studies and seems to reduce the duration of other
inotrope use. However, long-term safety or efficacy data are
lacking [7].
Infants hypotensive according to the GA criteria but with
clinical evidence of good perfusion have been shown to have
outcome as good as normotensive patients, and treated low BP
was associated with adverse outcome [2]. The concept of
‘permissive hypotension’—not intervening for a specific BP
Table 4 Practice variation in different region
Region 

















Eastern Europe 3,7% 17,1% 16,7% 7,4% 11,4%
Northern Europe 33,3% 22,0% 33,3% 45,6% 
+
35,3%
Southern Europe 48,1% 
+++
4,9% 10,4% 10,3% 14,7%
Western Europe 7,4% 31,7% 
+
20,8% 19,1% 20,7%
Other countries 7,4% 24,4% 18,8% 17,6% 17,9%
TwoStep Cluster Analysis and Crosstabulation According Region. Variables from the survey questions addressing treatment regiment were subjected to
the TwoStep Cluster analysis to identify responder groups who follow similar course of treatment. The algorithm identified four different clusters as
demonstrated by coloured columns. Cluster distribution in different regions was compared using χ2 -test (asymptotic, exact and Monte Carlo,
respectively). Significant differences among clusters are expressed as sign scheme. Level of significance 95 %, respectively 99,9 % is expressed as +
(p<0,05) and +++(p<0,001), respectively
Eastern Europe: Czech Republic, Slovakia, Poland, Ukraine, Russia Northern Europe: United Kingdom, Ireland, Denmark, Norway, Sweden, Iceland,
Latvia, Finland Southern Europe: Spain, Greece, Portugal, Italy, Turkey, Croatia, Slovenia Western Europe: Belgium, Germany, Netherlands, France,
Switzerland and Others countries: United States, Saudi Arabia, Australia, New Zealand, South Africa, Brazil, Egypt, Israel, Japan, Canada, Lebanon,
Kuwait, United Arab Emirates
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value (typically one less than the GA) in the absence of other
signs of poor perfusion—seems to be gaining popularity as the
majority of respondents (80 %) stated that they would consid-
er using this approach.
Conclusion
The main criteria used to commence treatment for hypoten-
sion in ELGANs remains a mean BP in mmHg less than the
GA, and treatment predominantly comprises volume followed
by dopamine. There appears to be increasing use of point of
care echocardiography in the management of these patients,
though the benefit of this or other methods of assessment have
not been demonstrated. The HIP trial (http://www.hip-trial.
com/)—an international, multicentre double-blind, randomised,
placebo controlled trial of dopamine for treatment of mean BP
less than GA in a planned sample of 830 extremely preterm
infants—will provide new information in this area. The role of
ancillary methods of assessment including echocardiography,
near infrared spectroscopy and electroencephalograhy will be
assessed in a planned subgroup of infants.
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